Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Electromotive Mitomycin for High Risk Urothelial Non-muscle Invasive Bladder Cancer After Intravesical Bacillus Calmette-Guérin Failure

NCT04311580 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT04311580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04311580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Electromotive Mitomycin for High Risk Urothelial Non-muscle Invasive Bladder Cancer After Intravesical Bacillus Calmette-Guérin Failure
Lead sponsor
University of Rome Tor Vergata
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2000
Completion date
March 10, 2020
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer